Barclays’s Concordia International Corp. Common Stock CXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-25,606
Closed -$12K 7572
2018
Q1
$12K Buy
25,606
+25,600
+426,667% +$16.8K ﹤0.01% 6617
2017
Q4
$0 Hold
6
﹤0.01% 7290
2017
Q3
$0 Hold
6
﹤0.01% 7231
2017
Q2
$0 Hold
6
﹤0.01% 7161
2017
Q1
$0 Sell
6
-11,200
-100% -$24.1K ﹤0.01% 7147
2016
Q4
$24K Buy
11,206
+11,065
+7,848% +$33.9K ﹤0.01% 5540
2016
Q3
$1K Buy
+141
New +$1.77K ﹤0.01% 6533
2016
Q2
Sell
-333
Closed -$8.77K 6842
2016
Q1
$8K Sell
333
-598
-64% -$17.9K ﹤0.01% 5555
2015
Q4
$37K Buy
+931
New +$32.8K ﹤0.01% 4962

Other funds holding CXRX

Barclays's CXRX Position: Q2 2018 in Review

Barclays sold out of Concordia International Corp. Common Stock (CXRX) in Q2 2018, closing a stake of 25,606 shares — an estimated $12K sold.

Barclays first reported a position in CXRX in Q4 2015 and held it in 9 quarters. The position peaked at $37K in Q4 2015. 4 funds tracked by Wall St. Rank hold CXRX as of Q2 2018.

  • Barclays reported no remaining Concordia International Corp. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Barclays sold 25,606 Concordia International Corp. Common Stock shares in Q2 2018, an estimated $12K.
  • Barclays first reported a position in Concordia International Corp. Common Stock in Q4 2015 and held it in 9 quarters.
  • Barclays's Concordia International Corp. Common Stock position peaked at $37K in Q4 2015.
  • 4 funds tracked by Wall St. Rank held Concordia International Corp. Common Stock as of Q2 2018.

Based on Barclays's 13F filing for Q2 2018, filed 14 Aug 2018.